NASPAG'S Response to Texas Senate Bill 8

NASPAG’s mission is to advocate for the reproductive well-being of children and adolescents and the provision of unrestricted, unbiased, and evidence-based practice of Pediatric and Adolescent Gynecology. The Texas Senate Bill 8 undermines the ability of Pediatric and Adolescent health care providers to align with NASPAG’s mission. This bill impacts critical reproductive health care, which undoubtedly will disproportionately impact those with poorest resources and access to care. This is one of the most restrictive abortions bans in the US, making abortion illegal with no exceptions for rape, sexual abuse, incest, or fetal anomaly diagnosis.  

Read more

Talking points - COVID-19 Vaccine and Reproductive Health

With ongoing COVID-19 surges, the need for vaccine uptake among adolescent and young adults is critical to safety and decreasing transmission. Although there is no preferred vaccine formulation, the Pfizer-BioNtech vaccine is the sole formulation that received full FDA approval. Twelve to seventeen-year olds are currently only eligible to receive the Pfizer-BioNtech vaccine. The FDA has also recently approved the Pfizer-BioNtech vaccine for those 5-11 years of age, and it is anticipated that other countries will approve the same in the coming weeks around the world.

Read More

The Future of Abortion Care

NASPAG will continue to support and advocate for comprehensive sexual and reproductive care for all.  We continue to oppose legislation that interferes in the patient - health care provider relationship.  Please see this ACOG Message for a summary of strategies that supports access to and provision of abortion care.

Read more

Joint Statement on Adolescents and Young Adults following Dobbs v. Jackson Women’s Health Organization

The Supreme Court’s ruling in Dobbs v. Jackson is an egregious attack on bodily autonomy, removing a pregnant person’s right to autonomous decision making over the most personal and most consequential of life decisions. While this is devastating for all persons, adolescents and young adults will suffer greatly from this decision. This ruling reversed nearly 50 years of legal precedent, issued a direct assault on reproductive justice and the public’s health, and curtailed the status of pregnant persons as free and equal citizens (as noted in the dissenting opinion). We are collectively opposed to this violation of human rights, which will be especially harmful to vulnerable and marginalized populations including adolescents and young adults. We object to any restrictions placed on the reproductive rights of adolescents and young adults. Access to safe abortion is a basic part of comprehensive reproductive health care. This ruling contradicts the broad medical and scientific consensus that abortion is a fundamental component of healthcare, abortion is safe, and abortion is a human right.

Adolescents and young adults already face more barriers than adults in accessing comprehensive reproductive healthcare services and abortion care, such as cost, confidentiality concerns, and limited knowledge and experience seeking healthcare. This ruling means that abortion services will be either obliterated or severely limited in many geographic areas. Remaining avenues for accessing abortion care will be difficult if not impossible for young people, putting their futures, health, and safety at risk. Marginalized individuals and communities and those who experience systemic oppression are also uniquely vulnerable.

Bright Girl Skincare - Exclusive Discount for NASPAG Members

Hello NASPAG members:

I’m Angela Sanfilippo Casey MD, a double Board-certified dermatologist and daughter of NASPAG member Joseph Sanfilippo MD, MBA. I’m also the founder of Bright Girl skincare for teens/tweens. A line formulated to be clean, gentle, and efficacious...specifically for young skin.
 
I had the pleasure of meeting many of you at the recent NASPAG conference in Nashville. To recognize this organization and its members, I’ve created an online purchase code (NASPAG25) offering our greatest retail discount ever. We’ll provide a 25% discount at checkout, while also donating 25% of all sales back to NASPAG. 
 
To support this initiative, enter code NASPAG25 at checkout on the Bright Girl website.

Advocacy Committee Review of Prescription to OTC Switch for Norgestrel

OnTuesday, May 9th, NASPAG was one of 37 different organizations and/or individuals to speak at the Open Public Hearing session of the joint meeting of the Nonprescription Drugs Advisory Committee and the Obstetrics, Reproductive and Urologic Drugs Advisory Committee of the FDA. The Advisory Committee was assembled to review the application from HRA Pharma for a "prescription-to-OTC" switch for Norgestrel 0.075mg (Opill) as a progestin-only oral contraceptive. Speakers included several major medical societies, reproductive justice and advocacy organizations, and many youth who boldly shared their personal stories! Out of the 37 speakers, 35 spoke in strong support of the proposal. 

Welcome to NASPAG! 

Whether you are a decades-long NASPAG supporter, a colleague looking for support in caring for your patient, a student learning about pediatric gynecology for the first time,  or anything in between, we are glad you are here! NASPAG is an incredibly vibrant organization filled with members dedicated to improving the reproductive health of youth through evidence-based clinical care, advocacy, education, and research. Our annual meeting energizes us (see you April 4-6 in Orlando), but we know this website is where you need to come to connect and find helpful resources the rest of the year, so welcome! 

Congratulations!

Our 2024 Annual Clinical Research Meeting will be held on April 4 - 6 in Orlando

Thank you for a tremendous ACRM 2023!